| Home > Publications Database > The brain as immunoprecipitator of serum autoantibodies against N-Methyl-D-aspartate receptor subunit NR1. |
| Journal Article | DZNE-2020-04715 |
; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ;
2016
Wiley-Blackwell
Hoboken, NJ
This record in other databases:
Please use a persistent id in citations: doi:10.1002/ana.24545
Abstract: Autoantibodies (AB) against N-methyl-D-aspartate receptor subunit NR1 (NMDAR1) are highly seroprevalent in health and disease. Symptomatic relevance may arise upon compromised blood-brain barrier (BBB). However, it remained unknown whether circulating NMDAR1 AB appear in the cerebrospinal fluid (CSF). Of n = 271 subjects with CSF-serum pairs, 26 were NMDAR1 AB seropositive, but only 1 was CSF positive. Contrariwise, tetanus AB (non-brain-binding) were present in serum and CSF of all subjects, with CSF levels higher upon BBB dysfunction. Translational mouse experiments proved the hypothesis that the brain acts as an 'immunoprecipitator'; simultaneous injection of NMDAR1 AB and the non-brain-binding green fluorescent protein AB resulted in high detectability of the former in brain and the latter in CSF.
Keyword(s): Adult (MeSH) ; Animals (MeSH) ; Autoantibodies: blood (MeSH) ; Autoantibodies: cerebrospinal fluid (MeSH) ; Blood-Brain Barrier: physiopathology (MeSH) ; Brain: immunology (MeSH) ; Female (MeSH) ; Humans (MeSH) ; Male (MeSH) ; Mice (MeSH) ; Mice, Inbred C57BL (MeSH) ; Middle Aged (MeSH) ; Multiple Sclerosis: blood (MeSH) ; Multiple Sclerosis: cerebrospinal fluid (MeSH) ; Receptors, N-Methyl-D-Aspartate: immunology (MeSH) ; Seroepidemiologic Studies (MeSH) ; Autoantibodies ; NR1 NMDA receptor ; Receptors, N-Methyl-D-Aspartate
|
The record appears in these collections: |